Among the most-mutated genes, KRAS and TP53 were mutated only in cancers, while five other genes (HNF1A, CREBBP, RNF213, CASC5, and APC) were mutated with similar frequencies in adenocarcinomas and neuroendocrine tumors. This evidence concerns the gene KRAS and neuroendocrine neoplasm.